140 completed, 52 unknown, 36 recruiting, 21 terminated. 69 Not applicable, 55 Phase 2, 24 Phase 3, 21 Phase 4, 11 Phase 1.
Follow Sarcoidosis: new trials by email Literature Review of Sarcoidosis trials Research Report on Sarcoidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH) Placebo, LAM-001 - Sarcoidosis Associated Pulmonary Hypertension | Phase 2 | Not yet recruiting | IRulya Therapeutics Inc. | 60 | 2026-12-01 | 2026-10-21 |
| A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016) Tulisokibart, Placebo, Background prednisone therapy - Pulmonary Sarcoidosis | Phase 2 | Recruiting | Merck Sharp & Dohme LLC | 158 | 2026-11-03 | 2026-11-09 |
| Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis Prednisone, Compound betamethasone - Sarcoidosis, Pulmonary | Phase 2 / Phase 3 | Not yet recruiting | Peking Union Medical College Hospital | 126 | 2026-11-01 | 2026-10-15 |
| Cardiac Imaging in Systemic Disorders: the ORACLES Registry data collection - Lupus | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 1500 | 2026-11-01 | 2026-02-13 | |
| An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations XTMAB-16, Placebo - Pulmonary Sarcoidosis | Phase 2 | Not yet recruiting | Xentria, Inc. | 182 | 2026-10-30 | 2026-10-21 |
| Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD Gabapentin, Benzonatate 200 mg, Standard of care treatment for ILD - Interstitial Lung Disease | Phase 4 | Not yet recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 177 | 2026-10-07 | 2026-10-08 |
| Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool No Intervention: Observational Cohort - Optic Neuritis, Multiple Sclerosis | Not yet recruiting | King's College London | 180 | 2026-09-01 | 2026-07-15 | |
| FAPI PET Imaging - An Exploratory Study [18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N) | Phase 1 / Phase 2 | Not yet recruiting | Martin Huellner | 770 | 2026-08-01 | 2026-07-15 |
| Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS) Exosome Analysis - Cardiac Sarcoidosis, Sarcoidosis of the Heart | Recruiting | Mayo Clinic | 115 | 2026-07-13 | 2026-08-17 | |
| A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis Lung | Not yet recruiting | Cosmos Rx, Inc | 100 | 2026-07-01 | 2026-05-29 | |
| A Trial of Baricitinib in Patients With Cardiac Sarcoidosis Baricitinib (LY3009104) 4 mg - Cardiac Sarcoidosis | Phase 2 | Not yet recruiting | Stanford University | 10 | 2026-04-01 | 2026-02-10 |
| Corticosteroid Tapering in Sarcoidosis Standard prednisolone taper, Fast prednisolone taper - Sarcoidosis | Not applicable | Recruiting | Royal Brompton & Harefield NHS Foundation Trust | 100 | 2026-03-19 | 2026-03-27 |
| Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis EBUS-TBNA-based sampling methods, EBUS-TBMC based sampling method - Sarcoidosis, Pulmonary | Not applicable | Active not recruiting | China-Japan Friendship Hospital | 469 | 2026-03-01 | 2026-08-06 |
| Virtual Patient Groups for Sarcoidosis Associated Fatigue Virtual Mindfulness Based Stress Reduction Group, Virtual sarcoidosis support group - Sarcoidosis, Fatigue | Not applicable | Recruiting | The Cleveland Clinic | 100 | 2026-02-26 | 2026-04-24 |
| Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis Metformin, Cellulose - Sarcoidosis, Pulmonary | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2025-12-10 | 2025-02-11 | |
| Cohort of Patients With Systemic Granulomatosis and Associated Biological Collection blood sample, urine sample - Granulomatosis | Recruiting | University Hospital, Bordeaux | 150 | 2025-12-04 | 2026-02-03 | |
| EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases observational study - Myocarditis, ANCA Associated Vasculitis | Recruiting | Assistance Publique - Hôpitaux de Paris | 5000 | 2025-11-19 | 2026-06-05 | |
| Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development lymph node biopsy - Sarcoidosis Lung | Completed | Alexandria University | 40 | 2025-08-01 | 2026-01-15 | |
| A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis Oral Brepocitinib, Oral Placebo - Cutaneous Sarcoidosis | Phase 2 / Phase 3 | Recruiting | Priovant Therapeutics, Inc. | 168 | 2025-04-09 | 2026-11-03 |
| Tyrosine Kinase 2 (TYK2) for GA and CS Deucravacitinib - Sarcoidosis, Granuloma Annulare | Phase 2 | Withdrawn | Yale University | 2025-03-01 | 2025-04-29 |
Showing 20 of 282. Sign in to see all of them.
Sarcoidosis, Pulmonary (66) · Lung Diseases, Interstitial (32) · Pulmonary Fibrosis (21) · Lung Neoplasms (17) · Tuberculosis (16) · Idiopathic Pulmonary Fibrosis (15) · Hypertension, Pulmonary (14) · Lymphoma (14) · Fatigue (13) · Inflammation (12) · Pulmonary Disease, Chronic Obstructive (12) · Lung Diseases (10) · Asthma (8) · Behcet Syndrome (8)
Hemic and Lymphatic Diseases (282) · Hypersensitivity, Delayed (282) · Immune System Diseases (282) · Lymphatic Diseases (282) · Hypersensitivity (280) · Lymphoproliferative Disorders (280) · Respiratory Tract Diseases (141) · Lung Diseases (125) · Pathological Conditions, Signs and Symptoms (71) · Lung Diseases, Interstitial (69) · Pathologic Processes (56) · Cardiovascular Diseases (36) · Vascular Diseases (33) · Infections (31)
Prednisone (8) · Bronchoscopy (7) · Blood Specimen Collection (6) · Adrenocorticotropic Hormone (5) · Bronchoalveolar Lavage (5) · Adalimumab (4) · Azithromycin (4) · Observation (4) · Prednisolone (4) · Ethambutol (3) · Hydroxychloroquine (3) · Infliximab (3) · Levofloxacin (3) · Methotrexate (3) · Rifampin (3)
University of Cincinnati (15) · Assistance Publique - Hôpitaux de Paris (14) · Post Graduate Institute of Medical Education and Research, Chandigarh (13) · Maastricht University Medical Center (8) · National Heart, Lung, and Blood Institute (NHLBI) (8) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (5) · National Eye Institute (NEI) (4) · University of Aarhus (4) · Yale University (4) · Duke University (3) · Medical University of South Carolina (3) · National Jewish Health (3) · Novartis Pharmaceuticals (3) · Ohio State University (3) · Ottawa Heart Institute Research Corporation (3)
United States (122) · United Kingdom (32) · France (25) · Netherlands (25) · Germany (16) · India (16) · Denmark (15) · Italy (12) · Belgium (9) · Canada (9) · Turkey (Türkiye) (9) · Poland (8) · China (6) · Japan (6) · Israel (5)
Robert P Baughman, MD (11) · Marc A Judson, MD (4) · Aalt Bast, PhD (3) · Agnes W Boots, PhD (3) · Aliaa Barakat, PhD (3) · Michael Iannuzzi (3) · Rocco Trisolini, MD (3) · Andrew M Wilson, MD (2) · David Birnie, MD (2) · Don C Rockey, MD (2) · Elliott Crouser, MD (2) · Guido R Haenen, PhD (2) · Joel Moss, M.D. (2)
PMID 28775245, PMID 10228757, PMID 10767258, PMID 11451823, PMID 12045054, PMID 13148192, PMID 14899212, PMID 15225842, PMID 15618580, PMID 15824529, PMID 15855973, PMID 16100180, PMID 16315784, PMID 16840744, PMID 17099029, PMID 17426205, PMID 17643700, PMID 18256069, PMID 18263672, PMID 18494054, PMID 19117242, PMID 19188547, PMID 19395578, PMID 19884472, PMID 19897553, PMID 20013165, PMID 20298335, PMID 20560291, PMID 20926833, PMID 21030491, PMID 21086905, PMID 21299803, PMID 21324570, PMID 21420083, PMID 21436356, PMID 21482866, PMID 21629130, PMID 21732228, PMID 21796893, PMID 22004880, PMID 22284089, PMID 22434211, PMID 22652031, PMID 22733975, PMID 22859354, PMID 23002195, PMID 23070991, PMID 23139240, PMID 23433596, PMID 23433878
2017 (3), 2023 (3), 1UM1HL113115-01A1 (1), 2009 (1), 2014 (1), 2015 (1), 2018 (1), 2019 (1), 2025 (1), 5UL1RR024979 (1), K23HL148527 (1), K23MD017284 (1), R01HL054306 (1), R01HL117074 (1), R01HL157533 (1)